13

2024

-

11

On November 7, 2024, the Emergency Management Bureau of Yichang High-tech Zone issued a three-level safety production standardization enterprise (medicine) certificate to our company.

Author:

On November 7, 2024, the Emergency Management Bureau of Yichang High-tech Zone issued a three-level safety production standardization enterprise (medicine) certificate to our company.

On November 7, 2024, the Emergency Management Bureau of Yichang High-tech Zone issued a three-level safety production standardization enterprise (medicine) certificate to our company.

Related News

Breaking into the billion-dollar diabetes market! Hubei Guangchen secures the first generic version of linagliptin-metformin extended-release tablets.

Breaking into the billion-dollar diabetes market! Hubei Guangchen secures the first generic version of linagliptin-metformin extended-release tablets.

2025-11-01

On October 28, 2025, according to an announcement on the official website of the NMPA, the Lixagliptin-Metformin Extended-Release Tablets submitted by Hubei Guangchen Pharmaceutical Co., Ltd. have been approved for marketing (Approval Number: National Drug Approval No. H20255813), making it the first generic version of this dosage form in China. This approval fills a significant gap in the Chinese market for this extended-release formulation and is expected to provide type 2 diabetes patients with a more convenient medication option.

Hubei Guangchen Pharmaceutical Co., Ltd. held a 2025 first-half work summary meeting

Hubei Guangchen Pharmaceutical Co., Ltd. held a 2025 first-half work summary meeting

2025-07-25

On July 25, 2025, Hubei Guangchen Pharmaceutical Co., Ltd. held a 2025 first-half work summary meeting. The meeting was presided over by General Manager Chen Shaoyan, and all members of the company's board of directors and managers at the director level and above attended the meeting. Team leaders were also in attendance.

The Unveiling Ceremony for the Yichang Key Laboratory of Green Pharmaceutical Manufacturing was Held

The Unveiling Ceremony for the Yichang Key Laboratory of Green Pharmaceutical Manufacturing was Held

2025-06-07

The unveiling ceremony for the Yichang Key Laboratory of Green Manufacturing of Pharmaceuticals was held at the R&D center of Hubei Guangchen Pharmaceutical Co., Ltd. on June 6, 2025.

(Flash) Chairman Lei Shaoqing and General Manager Chen Shaoyan of the company visited the South Korean market.

(Flash) Chairman Lei Shaoqing and General Manager Chen Shaoyan of the company visited the South Korean market.

2025-04-28

From April 20 to 25, 2025, Mr. Lei Shaoqing, Chairman of the Board, and Mr. Chen Shaoyan, General Manager, along with Ms. Zhang Hua, Director of Quality, and Mr. Zou Rui, Minister of Safety and Environmental Protection, visited KUKJEON Pharmaceutical Co., Ltd., a South Korean client, for a five-day inspection of the sales situation of Guangchen products in the South Korean market. Through in-depth exchanges with clients and visits to downstream clients, both sides clarified the key points of their next cooperation, and both expressed their willingness to maintain stable cooperation and further expand market share.